Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Heterogeneous Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106543017B reveals a mild hydrogenation process for high-purity pharmaceutical intermediates, offering significant supply chain and cost advantages.
Advanced patent-based synthesis for high-purity dicyclohexyl crown ether. Optimized catalytic hydrogenation ensures cost efficiency and supply chain reliability for global buyers.
Patent CN107089898B details a green hydrogenation method for biomass phenolics. Discover cost-effective cyclohexanol production for pharmaceutical applications.
Patent CN114950452A reveals a novel Co-Y-Ce catalyst for high-purity L-2-aminopropanol synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN101395140B reveals a high-yield process for 2-imidazolidinones using solid acid catalysts and hydrogenation, offering significant cost and safety advantages for pharmaceutical intermediate manufacturing.
Patent CN1812990A details a novel Pd/C catalyzed route for famciclovir, achieving superior purity by minimizing hydrolysis impurities through optimized solvent systems.
Novel Cu/Nb2O5 catalyst enables efficient secondary amine production. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN106699507B details water-based hydrogenation for high-purity alpha-phenylethanol. This green process ensures supply chain reliability and significant cost reduction.
Patent CN108558679A details a mild nitration and hydrogenation route for Parylene A precursors, offering high purity and reduced environmental impact for electronic chemical manufacturing.
Novel Ru/C catalyzed hydrogenation and solvent-free isomerization route for high-purity liquid crystal intermediates with over 90% yield.
Advanced Pt/Bi catalytic hydrogenation technology for m-aminoacetophenone. Delivers superior selectivity, green processing, and reliable supply chain solutions for global pharmaceutical manufacturers.
Patent CN1634896A introduces a fixed-bed continuous method for piperazine synthesis, offering high selectivity and lower pressure operation for cost-effective pharmaceutical intermediate manufacturing.
Novel Pd-Pt-Zn catalyst enables 98% CHDA selectivity. Reduces decarboxylation. Ideal for reliable fine chemical intermediate supplier partnerships.
Patent CN101429199B details a mild two-step racemization process for fluoroquinolone intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN101817779A reveals a novel nickel-catalyzed route for N-benzyl-3-piperidinol, offering safer manufacturing and significant cost reduction for Benidipine intermediates.
Patent CN101903366B details a novel ruthenium-catalyzed hydrogenation and isomerization process for producing high-purity cis-rose oxide, offering significant cost and supply chain advantages.
Patent CN108558673B reveals a cost-effective Raney Nickel process for high-purity 2-(1-cyclohexenyl)ethylamine, optimizing dextromethorphan intermediate supply chains.
Patent CN102344378B details aqueous hydrogenation for amino alcohol. Offers high purity and yield for pharmaceutical supply chains.
Patent CN102086165A reveals a novel Pd-catalyzed hydrogenation route for doxycycline intermediates, offering superior stereoselectivity and reduced environmental impact for pharmaceutical manufacturing.
Advanced Raney Nickel catalyzed synthesis of butylphthalide eliminates high-energy rectification. Delivers >99% purity for reliable API intermediate supply chains.